These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10700827)

  • 1. Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer.
    Hoskin PJ; Saunders MI; Goodchild K; Powell ME; Taylor NJ; Baddeley H
    Br J Radiol; 1999 Nov; 72(863):1093-8. PubMed ID: 10700827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast enhanced dynamic MRI of cervical carcinoma during radiotherapy: early prediction of tumour regression rate.
    Gong QY; Brunt JN; Romaniuk CS; Oakley JP; Tan LT; Roberts N; Whitehouse GH; Jones B
    Br J Radiol; 1999 Dec; 72(864):1177-84. PubMed ID: 10703475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced MRI in head-and-neck cancer: the impact of region of interest selection on the intra- and interpatient variability of pharmacokinetic parameters.
    Craciunescu OI; Yoo DS; Cleland E; Muradyan N; Carroll MD; MacFall JR; Barboriak DP; Brizel DM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e345-50. PubMed ID: 21985945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast enhanced-MRI in head and neck cancer patients: variability of the precontrast longitudinal relaxation time (T10).
    Craciunescu O; Brizel D; Cleland E; Yoo D; Muradyan N; Carroll M; Barboriak D; MacFall J
    Med Phys; 2010 Jun; 37(6):2683-92. PubMed ID: 20632579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory study into the role of dynamic contrast-enhanced (DCE) MRI metrics as predictors of response in head and neck cancers.
    Agrawal S; Awasthi R; Singh A; Haris M; Gupta RK; Rathore RK
    Clin Radiol; 2012 Sep; 67(9):e1-5. PubMed ID: 22583950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravoxel incoherent motion diffusion-weighted imaging in head and neck squamous cell carcinoma: assessment of perfusion-related parameters compared to dynamic contrast-enhanced MRI.
    Fujima N; Yoshida D; Sakashita T; Homma A; Tsukahara A; Tha KK; Kudo K; Shirato H
    Magn Reson Imaging; 2014 Dec; 32(10):1206-13. PubMed ID: 25131628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The weighting of SE, IE and GE sequences in tumors of the head and neck].
    Wagner-Manslau C; Bauer R; van de Flierdt E; Lukas P; Clasen B; Hässler A; Pabst HW
    Rofo; 1990 Aug; 153(2):154-60. PubMed ID: 2168070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic MR imaging in the head and neck.
    Takashima S; Noguchi Y; Okumura T; Aruga H; Kobayashi T
    Radiology; 1993 Dec; 189(3):813-21. PubMed ID: 8234709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas.
    Quon H; Brizel DM
    Semin Radiat Oncol; 2012 Jul; 22(3):220-32. PubMed ID: 22687947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
    Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
    Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative dynamic contrast enhanced MRI of recurrent pelvic masses in patients treated for cancer.
    Hawnaur JM; Zhu XP; Hutchinson CE
    Br J Radiol; 1998 Nov; 71(851):1136-42. PubMed ID: 10434907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted Magnetic Resonance Imaging in Differentiating Recurrent Head and Neck Cancer From Postradiation Changes.
    Abdel Razek AA; Gaballa G; Ashamalla G; Alashry MS; Nada N
    J Comput Assist Tomogr; 2015; 39(6):849-54. PubMed ID: 26359584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced MRI in the differentiation of posttreatment fibrosis from recurrent carcinoma of the head and neck.
    Semiz Oysu A; Ayanoglu E; Kodalli N; Oysu C; Uneri C; Erzen C
    Clin Imaging; 2005; 29(5):307-12. PubMed ID: 16153535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
    Razek AA; Megahed AS; Denewer A; Motamed A; Tawfik A; Nada N
    Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A five-colour colour-coded mapping method for DCE-MRI analysis of head and neck tumours.
    Yuan J; Chow SK; Yeung DK; King AD
    Clin Radiol; 2012 Mar; 67(3):216-23. PubMed ID: 21939962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The initial clinical experiences with a dynamic FLASH-2D sequence in tumors of the head and neck area].
    Mäurer J; Hellwig A; Matthaei D; Carduck HP
    Rofo; 1993 May; 158(5):451-5. PubMed ID: 8490154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor plasma flow determined by dynamic contrast-enhanced MRI predicts response to induction chemotherapy in head and neck cancer.
    Bernstein JM; Kershaw LE; Withey SB; Lowe NM; Homer JJ; Slevin NJ; Bonington SC; Carrington BM; West CM
    Oral Oncol; 2015 May; 51(5):508-13. PubMed ID: 25700703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications for gadolinium-DTPA in magnetic resonance evaluation of extracranial head and neck mass lesions: review of experience with 27 patients examined with a 2 tesla imager.
    Chisin R; Gomori JM; Elidan J
    Isr J Med Sci; 1992; 28(3-4):268-76. PubMed ID: 1592599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.